LPL Financial’s PDS Biotechnology PDSB Stock Holding History
Bought
Maintained
Sold
Other funds holding PDSB
LPL Financial's PDSB Position: Q4 2024 in Review
LPL Financial sold out of PDS Biotechnology (PDSB) in Q4 2024, closing a stake of 10,412 shares — an estimated $39.8K sold.
LPL Financial first reported a position in PDSB in Q4 2016 and held it in 13 quarters. The position peaked at $5M in Q4 2022. 52 funds tracked by Wall St. Rank hold PDSB as of Q4 2024.
- LPL Financial reported no remaining PDS Biotechnology position as of Q4 2024 after selling out during the quarter.
- LPL Financial sold 10,412 PDS Biotechnology shares in Q4 2024, an estimated $39.8K.
- LPL Financial first reported a position in PDS Biotechnology in Q4 2016 and held it in 13 quarters.
- LPL Financial's PDS Biotechnology position peaked at $5M in Q4 2022.
- 52 funds tracked by Wall St. Rank held PDS Biotechnology as of Q4 2024.
Based on LPL Financial's 13F filing for Q4 2024, filed 11 Feb 2025.